Global Benign Prostatic Hyperplasia Devices Market Growth 2023-2029

Global Benign Prostatic Hyperplasia Devices Market Growth 2023-2029

Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.

LPI (LP Information)' newest research report, the “Benign Prostatic Hyperplasia Devices Industry Forecast” looks at past sales and reviews total world Benign Prostatic Hyperplasia Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Benign Prostatic Hyperplasia Devices sales for 2023 through 2029. With Benign Prostatic Hyperplasia Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Benign Prostatic Hyperplasia Devices industry.

This Insight Report provides a comprehensive analysis of the global Benign Prostatic Hyperplasia Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Benign Prostatic Hyperplasia Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Benign Prostatic Hyperplasia Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Benign Prostatic Hyperplasia Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Benign Prostatic Hyperplasia Devices.

The global Benign Prostatic Hyperplasia Devices market size is projected to grow from US$ 372.7 million in 2022 to US$ 499.2 million in 2029; it is expected to grow at a CAGR of 499.2 from 2023 to 2029.

The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications

This report presents a comprehensive overview, market shares, and growth opportunities of Benign Prostatic Hyperplasia Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others

Segmentation by application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH

Key Questions Addressed in this Report

What is the 10-year outlook for the global Benign Prostatic Hyperplasia Devices market?

What factors are driving Benign Prostatic Hyperplasia Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Benign Prostatic Hyperplasia Devices market opportunities vary by end market size?

How does Benign Prostatic Hyperplasia Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.